✦ LIBER ✦

A novel gene STYK1/NOK is upregulated in estrogen receptor-alpha negative estrogen receptor-beta positive breast cancer cells following estrogen treatment

✍ Scribed by K. Sean Kimbro; Kaitlin Duschene; Margeret Willard; Jodi-Ann Moore; Shalonda Freeman

Publisher: Springer
Year: 2007
Tongue: English
Weight: 187 KB
Volume: 35
Category: Article
ISSN: 0301-4851
DOI: 10.1007/s11033-006-9047-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gene expression of topoisomerase II alph

Gene expression of topoisomerase II alpha (TOP2A) by microarray analysis is highly prognostic in estrogen receptor (ER) positive breast cancer

✍ A. Rody; T. Karn; E. Ruckhäberle; V. Müller; M. Gehrmann; C. Solbach; A. Ahr; R. 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 370 KB

KAI1/CD82 is a novel target of estrogen

KAI1/CD82 is a novel target of estrogen receptor-mediated gene repression and downregulated in primary human breast cancer

✍ Matthias Christgen; Henriette Bruchhardt; Matthias Ballmaier; Till Krech; Floria 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 749 KB

## Abstract The cell‐surface glycoprotein KAI1 suppresses tumor growth and metastasis in various animal models. Downregulation of KAI1 has been implicated in the progression of cancer. However, the mechanisms of KAI1 inactivation are poorly understood. This is the first study that investigates expr

KAI1/CD82 is a novel target of estrogen

KAI1/CD82 is a novel target of estrogen receptor-mediated gene repression and downregulated in primary human breast cancer (Int J Cancer 123: 2239–2246, 2008)

✍ Joseph Geradts 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 43 KB 👁 1 views

With interest I read the article by Christgen et al. that was recently published under the Fast Track heading in the International Journal of Cancer. 1 The major reported findings, nicely summarized in the article's title, are that (a) KAI1/CD82 is downregulated in 77% of human breast carcinomas and